Deep Genomics vs Relay Therapeutics
Deep Genomics vs Relay Therapeutics, compared side by side on 17 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Deep Genomics is on 61/100 and Relay Therapeutics on 58/100.
Where each one leads
Deep Genomics
- domain rating: 54/100 against 45/100
Relay Therapeutics
- agent readiness: 39/100 against 35/100
- funding raised: $825M against $241M
At a glance
| Measure | Deep Genomics | Relay Therapeutics |
|---|---|---|
| What it is | AI-powered biotechnology company developing RNA therapeutics for genetic diseases. | Clinical-stage precision medicine company using protein motion insights for drug discovery. |
| Category | Biotech, Drug Discovery, Genomics, AI-Driven Drug Discovery | Biotech, Drug Discovery, Precision Medicine, Oncology |
| Sells toBusiness model | B2B | B2B |
| Offering | Platform | Platform |
| Founded | 2015 | 2015 |
| Headquarters | Toronto, Canada | Cambridge, United States |
| Status | Active | Active |
Size, funding and growth
| Measure | Deep Genomics | Relay Therapeutics |
|---|---|---|
| Employees | 110 | Not published |
| Headcount growthLast 12 months | +19.3% | Not published |
| Total funding | $241M | $825M |
| Latest round | Series C | Public Offering |
| LinkedIn followers | 30,891 | Not published |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Deep Genomics | Relay Therapeutics |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 61/100 | 58/100 |
| Traction | 60/100 | 40/100 |
| Team | 60/100 | 70/100 |
| Community | Not published | 8/100 |
| Search visibility | 33/100 | 14/100 |
| Quality | 68/100 | 68/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (35/100) | F (39/100) |
| Domain ratingLink authority, 0-100 | 54/100 | 45/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Deep Genomics | Relay Therapeutics |
|---|---|---|
| Hosting | Self Managed | Not detected |
| CDN | Not detected | Cloudflare |
| CMS | Not detected | WordPress |
| Frameworks | Not detected | Jquery |
| Analytics | Google Analytics 4, Segment | Linkedin Insight |
Deep Genomics vs Relay Therapeutics: common questions
Which is better, Deep Genomics or Relay Therapeutics?
On our 0-100 score Deep Genomics rates higher (61/100 against 58/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 17 data points above: read the rows that match what you are buying for.
How do Deep Genomics and Relay Therapeutics compare on the numbers?
Deep Genomics leads on domain rating (54/100 against 45/100). Relay Therapeutics leads on agent readiness (39/100 against 35/100), funding raised ($825M against $241M).
Read the full Deep Genomics review and pricing or the Relay Therapeutics review and pricing. You can also browse other Deep Genomics alternatives we track.